Andrew Feber
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 14
- Cancer-related molecular mechanisms research 6
- Otorhinolaryngology top 2%
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 29
- RNA modifications and cancer 19
- Cancer-related gene regulation 7
- Oncology top 5%
- Cancer-related Molecular Pathways 6
- Genetics top 5%
-
- Bladder and Urothelial Cancer Treatments 18
- Urinary and Genital Oncology Studies 10
- Co-authors
- Stephan BeckAndrew E. TeschendorffTiffany MorrisAnkur ChakravarthyAmy P. WebsterLee M ButcherZhen YangTomasz K. Wojdacz
- Journals
- Genome Medicine (7 papers)Journal of Clinical Oncology (4 papers)The Journal of Urology (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Andrew Feber
67 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 1.5k
- Otorhinolaryngology 220
- Molecular Biology 3.1k
- Oncology 823
- Genetics 221
Countries citing papers authored by Andrew Feber
This map shows the geographic impact of Andrew Feber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Feber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Feber more than expected).
Fields of papers citing papers by Andrew Feber
This network shows the impact of papers produced by Andrew Feber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Feber. The network helps show where Andrew Feber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Feber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 6 | |
| 4 | 2020 | 64 | |
| 5 | 2020 | 5 | |
| 6 | 2018 | 57 | |
| 7 | 2018 | 69 | |
| 8 | 2018 | 195 | |
| 9 | 2017 | 14 | |
| 10 | 2017 | 13 | |
| 11 | 2016 | 45 | |
| 12 | 2014 | 43 | |
| 13 | 2014 | 19 | |
| 14 | 2014 | 22 | |
| 15 | 2013 | 105 | |
| 16 | 2012 | 98 | |
| 17 | 2008 | 90 | |
| 18 | 2006 | 102 | |
| 19 | 2004 | 134 | |
| 20 | 2003 | 81 |
About Andrew Feber
Andrew Feber is a scholar working on Cancer Research, Otorhinolaryngology, Urology, Surgery and Molecular Biology, having authored 68 papers that have together received 4.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (29 papers), RNA modifications and cancer (19 papers), Bladder and Urothelial Cancer Treatments (18 papers), Cancer Genomics and Diagnostics (14 papers), Urinary and Genital Oncology Studies (10 papers), Cancer-related gene regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Cancer Research (1.5k citations), Otorhinolaryngology (220 citations), Molecular Biology (3.1k citations), Oncology (823 citations) and Genetics (221 citations). Andrew Feber has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stephan Beck, Andrew E. Teschendorff, Tiffany Morris, Ankur Chakravarthy, Amy P. Webster, Lee M Butcher, Zhen Yang, Tomasz K. Wojdacz, Yuan Tian and Tim R. Fenton. Their work appears in journals such as Genome Medicine, Journal of Clinical Oncology, The Journal of Urology, British Journal of Urology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.